Skip to content
10-K

Annual Report

Traws Pharma, Inc. TRAW

0001104659-26-043832

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Apr 13, 2026 10.16M sh
Shares Diluted FY 2024 · Dec 31, 2025 8.38M sh
Shares Diluted FY 2024 · Dec 31, 2024 1.55M sh
Operating Cash Flow FY 2024 · Dec 31, 2025 −$18.19M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$29.79M
Current Liabilities FY 2024 · Dec 31, 2025 $11.15M
Current Liabilities FY 2024 · Dec 31, 2024 $11.53M
Total Liabilities FY 2024 · Dec 31, 2025 $11.25M
Total Liabilities FY 2024 · Dec 31, 2024 $56.59M
Current Assets FY 2024 · Dec 31, 2025 $7.98M
Current Assets FY 2024 · Dec 31, 2024 $24.95M
Total Assets FY 2024 · Dec 31, 2025 $10.62M
Total Assets FY 2024 · Dec 31, 2024 $24.96M
Eps Diluted FY 2024 · Dec 31, 2025 $0.82
Eps Diluted FY 2024 · Dec 31, 2024 −$35.21
Eps Basic FY 2024 · Dec 31, 2025 $0.83
Eps Basic FY 2024 · Dec 31, 2024 −$35.21
Sga Expense FY 2024 · Dec 31, 2025 $8.52M
Sga Expense FY 2024 · Dec 31, 2024 $12.29M
Net Income FY 2024 · Dec 31, 2025 $9.17M
Net Income FY 2024 · Dec 31, 2024 −$166.52M
Operating Income FY 2024 · Dec 31, 2025 −$17.88M
Operating Income FY 2024 · Dec 31, 2024 −$142.37M